Page last updated: 2024-08-23

4-methoxyamphetamine and Cirrhosis

4-methoxyamphetamine has been researched along with Cirrhosis in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (28.57)29.6817
2010's3 (42.86)24.3611
2020's2 (28.57)2.80

Authors

AuthorsStudies
Ballesteros, MÁ; Barreda, P; Belmar, L; Gómez Ortega, JM; Gómez-Román, J; Mazón, J; Miñambres, E; Rodrigo, E; Ruiz, JC; Valero, R1
Ganoza, A; Hariharan, S; Jorgensen, DR; Mehta, R; Molinari, M; Randhawa, PS; Sood, P; Tevar, AD; van der Windt, DJ; Wijkstrom, M1
Eppler, D; Gawaz, M; Geisler, T; Henes, JC; Kandolf, R; Klingel, K; Koetter, I; Kramer, U; Mueller, II; Mueller, KA; Roecken, M; Seizer, P; Zuern, CS1
Christiaans, MH; Cleutjens, JP; Daemen, MJ; Gelens, MA; Nieman, FH; Peutz-Kootstra, CJ; Steegh, FM; van Heurn, EL; van Hooff, JP; van Suylen, RJ1
Butler, CR; Chow, K; Friedrich, MG; Haykowsky, M; Isaac, D; Kim, D; Kumar, A; Paterson, I; Thompson, R; Toma, M1
D'Agostino, R; Hundley, WG; Mandapaka, S1
Arnold, R; Burmester, G; Hauptmann, S; Heymer, B; Hiepe, F; Massenkeil, G; Pest, S; Radbruch, A; Radtke, H; Rosen, O; Thiel, A1

Other Studies

7 other study(ies) available for 4-methoxyamphetamine and Cirrhosis

ArticleYear
Controlled Donation After Circulatory Death Using Normothermic Regional Perfusion Does Not Increase Graft Fibrosis in the First Year Posttransplant Surveillance Biopsy.
    Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation, 2022, Volume: 20, Issue:12

    Topics: Atrophy; Biopsy; Brain Death; Death; Fibrosis; Graft Survival; Humans; Kidney Transplantation; Organ Preservation; Perfusion; Retrospective Studies; Tissue and Organ Procurement; Tissue Donors

2022
Donation after circulatory death is associated with increased fibrosis on 1-year post-transplant kidney allograft surveillance biopsy.
    Clinical transplantation, 2021, Volume: 35, Issue:9

    Topics: Allografts; Biopsy; Brain Death; Death; Fibrosis; Graft Survival; Humans; Kidney; Kidney Transplantation; Retrospective Studies; Tissue and Organ Procurement; Tissue Donors

2021
Clinical and histopathological features of patients with systemic sclerosis undergoing endomyocardial biopsy.
    PloS one, 2015, Volume: 10, Issue:5

    Topics: Adult; Biopsy; Death; Defibrillators, Implantable; Echocardiography; Female; Fibrosis; Heart; Heart Failure; Heart Ventricles; Humans; Inflammation; Male; Middle Aged; Myocardium; Scleroderma, Systemic; Ventricular Dysfunction, Left

2015
Early loss of peritubular capillaries after kidney transplantation.
    Journal of the American Society of Nephrology : JASN, 2011, Volume: 22, Issue:6

    Topics: Adult; Aged; Atrophy; Biopsy; Brain Death; Capillaries; Cohort Studies; Death; Female; Fibrosis; Humans; Kidney Transplantation; Kidney Tubules; Living Donors; Male; Middle Aged; Retrospective Studies; Time Factors

2011
Late gadolinium enhancement in cardiac transplant patients is associated with adverse ventricular functional parameters and clinical outcomes.
    The Canadian journal of cardiology, 2013, Volume: 29, Issue:9

    Topics: Adult; Aged; Contrast Media; Death; Female; Fibrosis; Follow-Up Studies; Gadolinium DTPA; Heart Transplantation; Hospitalization; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Middle Aged; Myocardium; Postoperative Complications; Prognosis; Stroke Volume; Ventricular Dysfunction, Left; Ventricular Remodeling

2013
Does late gadolinium enhancement predict cardiac events in patients with ischemic cardiomyopathy?
    Circulation, 2006, Jun-13, Volume: 113, Issue:23

    Topics: Adult; Aged; Angina, Unstable; Confounding Factors, Epidemiologic; Contrast Media; Death; Fibrosis; Gadolinium; Humans; Middle Aged; Models, Cardiovascular; Myocardial Infarction; Myocardial Ischemia; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Risk; Tachycardia, Ventricular

2006
Cardiac death after autologous stem cell transplantation (ASCT) for treatment of systemic sclerosis (SSc): no evidence for cyclophosphamide-induced cardiomyopathy.
    Bone marrow transplantation, 2001, Volume: 27, Issue:6

    Topics: Cardiomyopathies; Cyclophosphamide; Death; Female; Fibrosis; Hematopoietic Stem Cell Transplantation; Humans; Middle Aged; Myocardium; Pulmonary Fibrosis; Scleroderma, Systemic; Transplantation, Autologous

2001